搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
搜狐
8 天
Svar Life Science-iLite CD3效应器,评估CD3介导的T细胞激活
双特异性T细胞结合剂Blinatumomab,针对B细胞上的CD19和T细胞上的CD3,并于2014年获得FDA批准用于治疗B细胞恶性肿瘤(1)。 Svar Life Science-iLite® CD3效应体测定细胞可以用于评估CD3介导的T细胞激活。 iLite CD3效应体测定细胞是经人工工程处理的细胞(Jurkat,ATCC #TIB-152)。
GitHub
9 天
3D modeling
Learn or level up your L337 game dev skills and build amazing games toge ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Reaches tentative union deal
G7 ministers back Ukraine
La Nina could arrive soon
Philip Zimbardo dies at 91
Frozen waffles recalled
Opioid suits settlement deal
Orionids meteor shower
Probes near miss in Austin
OK classroom Bible suit
PG&E shuts off power
Republicans appeal ruling
US deficit reaches $1.8T
At decade-high level
Judge unseals new evidence
Three Americans detained
NK sending troops to RU?
Nationwide blackout in Cuba
Antitrust ruling delayed
Fire prompts evacuations
Ex-MN congressman dies
$4M LAPD fentanyl seizure
NC breaks turnout record
Calif. oil refinery closure
Challenges military listing
Emergency abortion ruling
Bladder cancer drug pulled
Boat rider arrested in FL
School shooting report
Hurricane Oscar forms
To furlough 700 workers
2024 induction ceremony
Netanyahu's home targeted
反馈